This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Vanderbilt University, Cedars-Sinai Medical Center. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,220 
1 out of 627 
Years Active: 2020-2026
Title: Andries Zijlstra: Innovator in Cancer Detection Technologies
Introduction
Andries Zijlstra is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of cancer detection through his innovative patents. With a total of 2 patents, Zijlstra's work focuses on improving methods for identifying clinically significant prostate cancer and characterizing cancer through advanced biological techniques.
Latest Patents
Zijlstra's latest patents include groundbreaking inventions that enhance cancer diagnostics. One of his patents, titled "Palmitoyl protein biomarkers in purified extracellular vesicles for early identification of clinically significant prostate cancer," provides methods for isolating large extracellular vesicles (EVs) and detecting palmitoyl proteins within them. This invention allows for the early identification of prostate cancer based on the presence of these proteins in patients. Additionally, he has developed a patent titled "Characterization of cancer using detection of activated leukocyte cell adhesion molecule (ALCAM) shedding." This patent includes methods for characterizing and monitoring cancer by determining the presence of shed ALCAM in biological samples, which can be crucial for diagnosing and evaluating treatment efficacy.
Career Highlights
Throughout his career, Andries Zijlstra has worked with prestigious institutions, including Vanderbilt University and Cedars-Sinai Medical Center. His research has significantly impacted the field of oncology, particularly in the development of diagnostic tools that can lead to better patient outcomes. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Zijlstra has collaborated with talented professionals in his field, including Amanda G. Hansen and Shanna Arnold. These collaborations have further enriched his research and contributed to the advancement of cancer detection technologies.
Conclusion
Andries Zijlstra's contributions to cancer detection through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work continues to pave the way for advancements in cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile